Dr. Christopher Ting

Dr. Christopher Ting is the Group CEO & Founder of Pathology Asia Holdings. He was previously responsible for heading Healthscope’s pathology interest in South East Asia. During his 6 years tenure, he implemented a number of quality and strategic initiatives which repositioned the businesses and allowed them to hold market leadership positions in their respective countries at the time of his departure. Dr. Ting also brings unique insights into the healthcare scene in Singapore and Malaysia. He has worked at the Biomedical Sciences Group of the EDB Singapore, and has been a lead participant in the healthcare sector within Malaysia’s Economic Transformation Programme (ETP).